First order to VibroSense Dynamics in the area of treatment of cancer with Chemotherapy
VibroSense Dynamics (VibroSense) has received a first commercial purchase order targeting Chemotherapy-Induced Peripheral Neuropathy (CIPN). The department of Oncology at Linköping University Hospital has signed a “pay per use” agreement for the VibroSense Meter product.The department of Oncology at Linköping University Hospital has signed a license agreement with VibroSense Dynamics. The clinic shall test the VibroSense Meter instrument and Multi Frequency Vibrometry for six months. The aim is to investigate the extent of nerve damage in patients treated with Chemotherapy. All patients